Roivant Sciences Ltd.
5.57xPrice / book
Market cap
$25.23B
Tangible equity
—
Price / tangible book
—
Price / book
5.57x
Return on equity
-6.6%
Return on assets
-5.3%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: ROIV stock price at premium vs MTB $34.93 current versus $7.44 implied using P/B multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MTB's multiple
Implied fair value · at ROIV's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple premium
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: ROIV FY 2026 (ended Mar 31, 2026) · MTB FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
$25.23B
Tangible equity
—
Price / tangible book
—
Price / book
5.57x
Return on equity
-6.6%
Return on assets
-5.3%
Efficiency ratio
—
Price / tangible book
Market cap
$34.64B
Tangible equity
$20.65B
Price / tangible book
1.68x
Price / book
1.19x
Return on equity
9.8%
Return on assets
1.3%
Efficiency ratio
41.5%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROIVANT SCIENCES LTD. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
M&T BANK CORPORATION · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.09x
0.45x
Net debt / EBITDA
Leverage against operating earnings
24.52x
—
Cash and equivalents
Liquid reserves on the balance sheet
$4.29B
—
Total debt
Interest-bearing obligations outstanding
$412.94M
$13.06B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Revolution Medicines, Inc.
ROIV vs RVMD
INCYTE CORP
ROIV vs INCY
Sarepta Therapeutics, Inc.
ROIV vs SRPT
EXELIXIS, INC.
ROIV vs EXEL
VERTEX PHARMACEUTICALS INC / MA
ROIV vs VRTX
JPMorgan Chase & Co.
ROIV vs JPM
Bank of America Corporation
ROIV vs BAC
Wells Fargo & Company
ROIV vs WFC
Citigroup Inc.
ROIV vs C
PNC FINANCIAL SERVICES GROUP, INC.
ROIV vs PNC
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.